Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Prevalence and correlates of cervical cancer screening among injection drug users.

Prevalence and correlates of cervical cancer screening among injection drug users. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Prevalence and correlates of cervical cancer screening among injection drug users. Abstract Text:

    bruce mcknightBruce McKnight,ian mcknightIan McKnight,thomas kerrThomas Kerr,kathy liKathy Li,julio montanerJulio Montaner,evan woodEvan Wood,

    OBJECTIVE: Access to cervical cancer screening may be lower among lower income and socially disadvantaged populations. However, few studies have specifically examined factors associated with cervical cancer screening among socially marginalized populations, especially in settings with free health care systems. METHODS: The present study was conducted to examine the prevalence and correlates of cervical cancer screening among injection drug users. We examined rates of Papanicolaou (Pap) smear testing among female participants in the Vancouver Injection Drug Users Study (VIDUS). Univariate and logistic regression analyses were used to evaluate factors associated with cervical cancer screening. RESULTS: During the period from December 2004 to May 2005, 297 female injection drug users were seen. In logistic regression analyses, age (adjusted odds ratio [AOR]=0.70; 95% confidence intervals [CI] 0.53, 0.92, P=0.010), HIV infection (AOR=2.46; 95% CI 1.41,4.26, P=0.001), hepatitis C infection (AOR=0.25; 95% CI 0.09,0.71, P=0.010), and having visited a family physician in the prior six months (OR=3.10; 95% CI 1.58, 6.07, P=0.001) were independently associated with recent cervical cancer screening. CONCLUSIONS: After adjustment for regular physician visits, HIV infection was associated with elevated rates of cervical screening. This is reassuring, given the elevated risk of cervical cancer among this population. Interventions may be required to improve uptake of screening among older injection drug users and drug users infected with hepatitis C.

    Prevalence and correlates of cervical cancer screening among injection drug users. Publishing Authors By Initials

    b mcknightB McKnight,i mcknightI McKnight,t kerrT Kerr,k liK Li,j montanerJ Montaner,e woodE Wood,

    For similar diagnosis: diagnostic techniques and procedures: diagnostic techniques, obstetrical and gynecological: vaginal smears research abstracts see: diagnosis: diagnostic techniques and procedures: diagnostic techniques, obstetrical and gynecological: vaginal smears research

    PUBMED ID PMID:

    MEDLINE DATE:

    Prevalence and correlates of cervical cancer screening among injection drug users. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of obstetrics and gynaecology Canada : JOG

    VOLUME: 28

    Page Numbers: 695-9

    Journal Abbreviation:

    ISSN: 1701-2163

    DAY: 3

    MONTH: Aug

    YEAR: 2006

    Prevalence and correlates of cervical cancer screening among injection drug users. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101126664

    Prevalence and correlates of cervical cancer screening among injection drug users. Keywords Mesh Terms:

    KEYWORDS: Vaginal Smears

    MESH TERMS: epidemiology

    Chemical & Substance for Abstract: Prevalence and correlates of cervical cancer screening among injection drug users. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Prevalence and correlates of cervical cancer screening among injection drug users.

    AFFILIATION: British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

    Country: Canada

    Canada Research PublicationCanada Research Publication

    AGENCY: United States NIDA

    GRANT: R01 DA011591-04A1

    ACRONYM: DA

    MEDLINETA: J Obstet Gynaecol Can

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Prevalence and correlates of cervical cancer screening among injection drug users Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News